Fig 1: ROC curve analysis of multiparametric classifiers for ovarian adnexal masses discrimination. Receiver operating characteristic (ROC) curves comparing the diagnostic performance of the ROMA and two multiparametric classifiers across three clinical comparisons: (a) malignant vs. benign tumors, (b) any tumor (benign or malignant) vs. control, and (c) malignant vs. others (control, benign tumors, and tumor-like lesions). ROMA (purple). Classifier 1 (pink) comprises CA-125, HE4, MRP8/14, and apoptosis parameters. Classifier 2 (blue) incorporates an extended nine-parameter panel, including CA-125, HE4, MRP8/14, apoptosis, OPN, SAA, IL-6, IL-8, and IGFBP-4. The area under the curve (AUC) is shown for each classifier. The multiparametric classifiers display the mean AUC +/− standard deviation from cross-validation, whereas the ROMA AUC is from a direct calculation. The white circles indicate the optimal operating points selected by maximizing Youden’s J index.
Fig 2: Serum concentrations of extracellular matrix remodeling enzymes and regulatory proteins. Serum concentrations of MMP-9, MMP-2, OPN (a), Cystatin C and IGFBP-4 (b) were determined in samples from healthy controls and women with benign or malignant adnexal masses using flow cytometry. Box-and-whisker plots display the median (central line), 25th–75th percentiles (box), and full data ranges (whiskers). Statistical significance is represented by * p < 0.05, and *** p < 0.001.
Supplier Page from BioLegend for LEGENDplex™ HU Vascular Inflam Panel 1 (12-plex) w/ VbP